These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28752901)

  • 21. Severe hypertriglyceridemia in a 6-year-old boy with ALL relapse: successfully treated with plasmapheresis.
    Winkler B; Kuhn S; Kunzmann S; Ruf K; Wiegering V; Schlegel PG
    Klin Padiatr; 2013 Nov; 225(6):364-5. PubMed ID: 24158897
    [No Abstract]   [Full Text] [Related]  

  • 22. Successful treatment with rivaroxaban of cerebral venous thrombosis and bone marrow necrosis induced by pegaspargase: A case report and literature review.
    Sui J; Zhang Y; Yang L; Wang H; Xu J; Wei R; Hao Y; Wang X; Peng J; Ma J
    Medicine (Baltimore); 2017 Nov; 96(46):e8715. PubMed ID: 29145310
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pegaspargase for acute lymphoblastic leukemia.
    Med Lett Drugs Ther; 1995 Mar; 37(944):23-4. PubMed ID: 7877556
    [No Abstract]   [Full Text] [Related]  

  • 24. Conservative management of L-asparaginase-induced hypertriglyceridemia in an adult patient: a case report and review of the literature.
    Seah J; Lin K; Tai D; Lim ST; Chan A
    Onkologie; 2012; 35(10):596-8. PubMed ID: 23038232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Advances on the role of pegaspargase in the treatment of childhood leukemia].
    Liu L; Xie XT
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Feb; 16(2):155-60. PubMed ID: 24568909
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pegaspargase (Oncaspar).
    Ettinger AR
    J Pediatr Oncol Nurs; 1995 Jan; 12(1):46-8. PubMed ID: 7893462
    [No Abstract]   [Full Text] [Related]  

  • 27. Cerebral sinus occlusion in a boy presenting with asparaginase-induced hypertriglyceridemia.
    Dietel V; Bührdel P; Hirsch W; Körholz D; Kiess W
    Klin Padiatr; 2007; 219(2):95-6. PubMed ID: 17405075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adolescent Male With Epigastric Pain.
    Cao C; Chan RY
    Ann Emerg Med; 2020 Apr; 75(4):546-557. PubMed ID: 32216884
    [No Abstract]   [Full Text] [Related]  

  • 29. A case report of an adult with severe hyperlipidemia during acute lymphocytic leukemia induction therapy successfully treated with plasmapheresis.
    Nakagawa M; Kimura S; Fujimoto K; Atumi H; Imura J; Chikazawa Y; Imamura H; Okuyama H; Yamaya H; Fukushima T; Nakagawa A; Asaka M; Yokoyama H
    Ther Apher Dial; 2008 Dec; 12(6):509-13. PubMed ID: 19140851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of hypertriglyceridemia in children with acute lymphoblastic leukemia under persistent therapy with glucocorticoids and L-asparaginase during induction chemotherapy.
    Salvador C; Meister B; Crazzolara R; Kropshofer G
    Pediatr Blood Cancer; 2012 Oct; 59(4):771. PubMed ID: 22619026
    [No Abstract]   [Full Text] [Related]  

  • 31. Pegaspargase: an alternative?
    Holle LM
    Ann Pharmacother; 1997 May; 31(5):616-24. PubMed ID: 9161659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Management of toxicities associated with pegaspargase in treatment of patients with lymphoid malignancy: experience from 443 cases in a single center].
    Cong J; Yang L; Ye J; Wei LQ; Li X; Wang JW
    Zhonghua Xue Ye Xue Za Zhi; 2018 Aug; 39(8):654-660. PubMed ID: 30180467
    [No Abstract]   [Full Text] [Related]  

  • 33. Asparaginase-associated pancreatitis is not predicted by hypertriglyceridemia or pancreatic enzyme levels in children with acute lymphoblastic leukemia.
    Raja RA; Schmiegelow K; Sørensen DN; Frandsen TL
    Pediatr Blood Cancer; 2017 Jan; 64(1):32-38. PubMed ID: 27555294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional acute liver failure after treatment with pegylated asparaginase in a patient with acute lymphoblastic leukemia: potential impact of plasmapheresis.
    Göpel W; Schnetzke U; Hochhaus A; Scholl S
    Ann Hematol; 2016 Oct; 95(11):1899-901. PubMed ID: 27488287
    [No Abstract]   [Full Text] [Related]  

  • 35. Pegaspargase in Practice: Minimizing Toxicity, Maximizing Benefit.
    Riley DO; Schlefman JM; Vitzthum Von Eckstaedt V HC; Morris AL; Keng MK; El Chaer F
    Curr Hematol Malig Rep; 2021 Jun; 16(3):314-324. PubMed ID: 33978914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse effects of pegaspargase in pediatric patients receiving doses greater than 3,750 IU.
    Lebovic R; Pearce N; Lacey L; Xenakis J; Faircloth CB; Thompson P
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28436558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A snapshot of asparaginase-induced liver insufficiency.
    Vetro C; Giulietti G; Calafiore V; Romano A; Di Raimondo F
    Eur J Haematol; 2014 Mar; 92(3):271-2. PubMed ID: 24329712
    [No Abstract]   [Full Text] [Related]  

  • 38. Hypertriglyceridemia during asparaginase treatment in children with acute lymphoblastic leukemia correlates with antithrombin activity in adolescents.
    Persson L; Harila-Saari A; Hed Myrberg I; Heyman M; Nilsson A; Ranta S
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28440015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asparaginase Erwinia chrysanthemi (Erwinaze®): a guide to its use in acute lymphoblastic leukemia in the USA.
    Keating GM
    BioDrugs; 2013 Aug; 27(4):413-8. PubMed ID: 23794007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. L-asparaginase-induced reversible posterior leukoencephalopathy syndrome in a child with acute lymphoblastic leukemia.
    Rathi B; Azad RK; Vasudha N; Hissaria P; Sawlani V; Gupta RK
    Pediatr Neurosurg; 2002 Oct; 37(4):203-5. PubMed ID: 12372914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.